Significados de concurrent chemoradiotherapy en inglés

In the adjuvant group, concurrent chemoradiotherapy was initiated 4 weeks after surgery.

Phase II trials using preoperative concurrent chemoradiotherapy have been tested with encouraging results.

If esophagectomy was indicated, it occurred 4 weeks after completion of concurrent chemoradiotherapy.

Therapy with concurrent chemoradiotherapy and female gender then became additional independent favorable predictors.

More recently, Phase II trials using concurrent chemoradiotherapy have been tested with encouraging results.

Patients without tumor progression were randomized to either chemotherapy alone or to concurrent chemoradiotherapy.

After three courses of induction chemotherapy, patients received concurrent chemoradiotherapy.

All patients received concurrent chemoradiotherapy followed by surgery; 72 patients also received irinotecan-based induction chemotherapy.

Patients and methods: We retrospectively analyzed data from 223 patients treated with definitive concurrent chemoradiotherapy.

Furthermore, two recent studies have concluded that concurrent chemoradiotherapy produces superior results to sequential administration.

All the patients received concurrent chemoradiotherapy as scheduled.

One and an additional five cycles of FOLFOX were delivered before and after concurrent chemoradiotherapy, respectively.

Preoperative concurrent chemoradiotherapy can improve the local and regional control, and certainly, more investigations will be needed.

There is emerging evidence for the use of adjuvant concurrent chemoradiotherapy in the group with high-risk features.

After concurrent chemoradiotherapy, 1 to 2 additional cycles of chemotherapy were administered.

Purpose: To investigate factors associated with treatment-related pneumonitis in non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.